Many cancer drugs remain unproven 5 years after accelerated approval, a study finds - The Associated Press
apnews.comSubmitted by associatedpress1467 in business
Researchers have found that most cancer drugs granted accelerated approval by the U.S. Food and Drug Administration do not deliver on their early promise. The program allows the FDA to grant early approval to drugs that show favorable initial results against …